Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Lester Thomas is listed as Executive Regulatory Sciences Director, Immunology Franchise at AstraZeneca, based in Durham, North Carolina, United States. AeroLeads shows a matched LinkedIn profile for Lester Thomas.
Lester Thomas previously worked as Senior Director Regulatory Affairs at Astrazeneca and Director Regulatory Affairs at Pearl Therapeutics. Lester Thomas holds Ba, Biology from University Of Colorado Boulder.
This section adds company-level context without repeating Lester Thomas's masked contact details.
Review company-level records connected to Lester Thomas before choosing the right outreach path.
I joined the biopharma industry in 1991 working on fludarabine for CLL and interferon beta for MS. Over the years, I've had the chance to work on nearly every type of platform: NCE’s, small and large molecules, monoclonal antibodies, a few medical devices, and various combinations of some or all of these. I've worked in both early and late-stage development in both very small (West Coast) and, now, very large (East Coast) organizations. My main focus currently is global regulatory strategy and team leadership in the immunology space.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Cambridge, Cambridgeshire, Gb
I currently lead a team of 10 Director & Sr Director level regulatory leaders (GRLs) charged with progressing AZ's biopharmaceutical portfolio in the Respiratory & Immunology TA. My team is accountable for all aspects for regulatory strategy and health authority engagement for three globally marketed monoclonal antibody products.
Cambridge, Cambridgeshire, Gb
I was the global regulatory strategy lead for the Aerospheres product franchise including, BEVESPI and BREZTRI.
Basking Ridge, New Jersey, Us
Among other things, I was the GRL for the FASENRA (benralizumab) severe eosinophilic asthma program, where I led the global marketing applications through to first approvals. Pearl was acquired by AstraZeneca in 2014 prior to my joining, and has since been absorbed fully into AZ.
Brentford, Middlesex, Gb
I was the Global Regulatory Leader for TRELEGY® (ICS/LABA/LAMA triple combination) in COPD, from inception through Phase III. Prior to that, I worked on a variety of development stage assets in neuroscience, inflammation, and ophthalmology.
Basel, Basel, Ch
Leader for all global regulatory activities related to development-stage biopharmaceutcals portfolio.
Emeryville, California, Us
I managed a small group responsible for all global regulatory activities. I led all the early work on Raptiva (anti-CD11a MAb).
New Brunswick, Nj, Us
I supported the MAA for AMPHOTEC and the NDA for DOXIL while at what was then known as Liposome Technology, Inc. (LTI)LTI later changed it's name to Sequus, then Sequus was acquired by Alza. Alza was later acquired by J&J.
Leverkusen, North Rhine-Westphalia, De
I supported the post-approval CMC commitments for FLUDARA (fludarabine phosphate) while at Triton/Berlex Biosciences. Later, Berlex was acquired by Bayer.
Quick answers generated from the profile data available on this page.
Lester Thomas works for AstraZeneca.
Lester Thomas is listed as Executive Regulatory Sciences Director, Immunology Franchise at AstraZeneca.
Lester Thomas is based in Durham, North Carolina, United States while working with AstraZeneca.
Lester Thomas has worked for Astrazeneca, Pearl Therapeutics, Glaxosmithkline, Syngenta Biotechnology, and Nektar Therapeutics.
You can use AeroLeads to view verified contact signals for Lester Thomas at AstraZeneca, including work email, phone, and LinkedIn data when available.
Lester Thomas holds Ba, Biology from University Of Colorado Boulder.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts